Antares Pharma Inc. | Mutual Funds
Mutual Funds that own Antares Pharma Inc.
Vanguard Total Stock Market Index Fund
3,582,297
2.27%
0
0%
07/31/2018
iShares Russell 2000 ETF
3,139,802
1.99%
-1,677
0.02%
09/06/2018
Vanguard Extended Market Index Fund
1,909,655
1.21%
0
0.01%
07/31/2018
HBM BioVentures Ltd.
1,751,510
1.11%
0
0.42%
12/31/2017
iShares Russell 2000 Growth ETF
1,461,274
0.93%
0
0.05%
09/06/2018
Fidelity Spartan Extended Market Index Fund
652,628
0.42%
0
0.01%
07/31/2018
Russell US Small Cap Equity Fund
622,623
0.4%
622,623
0.1%
04/30/2018
Schwab US Small Cap ETF
387,288
0.25%
0
0.02%
09/06/2018
iShares Micro Cap ETF
382,050
0.24%
0
0.12%
09/06/2018
338,213
0.22%
0
0.6%
09/05/2018
| Address |
100 Princeton South
Ewing New Jersey 08628
United States
|
|
Employees
|
- |
| Website |
http://www.antarespharma.com |
| Updated |
07/08/2019 |
| Antares Pharma, Inc. is a pharmaceutical company. The company focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its activities include the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. |
